nadp has been researched along with Prostatic Neoplasms in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (54.17) | 18.7374 |
| 1990's | 4 (16.67) | 18.2507 |
| 2000's | 1 (4.17) | 29.6817 |
| 2010's | 5 (20.83) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, R; Periasamy, A; Wallrabe, H | 1 |
| Huang, S; Ma, Y; Wang, S; Yang, Y; Yang, Z | 1 |
| Chen, HW; Hung, CL; Kung, HJ; Petrovics, G; Srivastava, S; Wang, LY; Yu, YL | 1 |
| Bost, F; Djabari, Z; Goiran, T; Laurent, K; Loubière, C; Tanti, JF | 1 |
| Cavallini, L; Chiarugi, P; Giannoni, E; Ippolito, L; Marini, A; Morandi, A; Pietrovito, L; Pintus, G; Puhr, M; Schrader, T; Taddei, ML | 1 |
| Benfodda, Z; Carbonneau, MA; Casas, F; Cristol, JP; Fajas, L; Fritz, V; Henriquet, C; Hure, S; Michel, F | 1 |
| KISER, WS; RIGGINS, RS | 1 |
| Aizawa, Y; Akiyama, Y; Goda, R; Ikemoto, I; Nagai, D; Nagata, K; Nishikawa, K; Yamazoe, Y | 1 |
| Bruchovsky, N; McLoughlin, MG; Rennie, PS; To, MP | 1 |
| Hudson, RW; Moffitt, PM; Owens, WA | 1 |
| Oshima, H; Troen, P; Yoshida, KI | 1 |
| Lack, L; Petrow, V; Sandberg, A; Wang, Y | 1 |
| Lack, L; Petrow, V | 1 |
| Coene, MC; Cools, W; Janssens, B; Krekels, MD; Van Ginckel, R; Van Hove, C; Wouters, W; Zimmerman, J | 1 |
| Jacobi, GH; Wilson, JD | 1 |
| Charles, JF; Floch, HH; Morfin, RF | 1 |
| Liang, T; Liao, S | 1 |
| Hudson, RW; Wherrett, D | 1 |
| Jutley, JK; Kelleher, J; Reaney, S; Whelan, P | 1 |
| Bailyes, E; Cooper, EH; Johannsson, A; Moss, DW; Self, CH; Siddle, K; Stanley, CJ; Whitaker, KB | 1 |
| Halgunset, J; Lundmo, PI; Sunde, A | 1 |
| Hilf, R; Miller, HC; Rector, W | 1 |
| Ochiai, K; Oshima, H; Sarada, T; Tamaoki, B | 1 |
| Baillie, AH; Mack, WS | 1 |
24 other study(ies) available for nadp and Prostatic Neoplasms
| Article | Year |
|---|---|
Multiphoton FLIM imaging of NAD(P)H and FAD with one excitation wavelength.
Topics: Antibiotics, Antineoplastic; Doxorubicin; Flavin-Adenine Dinucleotide; Fluorescence; Humans; Male; Microscopy, Fluorescence, Multiphoton; NADP; Photons; Prostatic Neoplasms; Tumor Cells, Cultured | 2020 |
miR-101 Enhances Cisplatin-Induced DNA Damage Through Decreasing Nicotinamide Adenine Dinucleotide Phosphate Levels by Directly Repressing Tp53-Induced Glycolysis and Apoptosis Regulator Expression in Prostate Cancer Cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Line; Cell Line, Tumor; Cisplatin; DNA Damage; Gene Expression Regulation, Neoplastic; Glucose; Glycolysis; Humans; Intracellular Signaling Peptides and Proteins; Male; MicroRNAs; NADP; Phosphoric Monoester Hydrolases; Prostatic Neoplasms | 2017 |
A long noncoding RNA connects c-Myc to tumor metabolism.
Topics: Aerobiosis; Cell Line, Tumor; Glycolysis; HEK293 Cells; Humans; Male; NADP; Pentose Phosphate Pathway; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Structure, Tertiary; Proto-Oncogene Proteins c-myc; Receptors, Androgen; RNA, Long Noncoding; RNA, Neoplasm | 2014 |
Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells.
Topics: Acetyl-CoA Carboxylase; Adenosine Triphosphate; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Fatty Acid Synthase, Type I; Humans; Lipogenesis; Male; Malonyl Coenzyme A; Metformin; NADP; Prostate; Prostatic Neoplasms; Sterol Regulatory Element Binding Protein 1 | 2015 |
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coculture Techniques; Docetaxel; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Fibroblasts; Glucose; Glutamine; Glycolysis; Humans; Male; Mitochondria; NADP; Oxidative Phosphorylation; Phenotype; Prostate; Prostatic Neoplasms; Reactive Oxygen Species; Taxoids | 2016 |
Metabolic intervention on lipid synthesis converging pathways abrogates prostate cancer growth.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; Fatty Acid Synthase, Type I; Humans; Male; Malonyl Coenzyme A; Mice, Nude; Molecular Targeted Therapy; NADP; NADPH Oxidases; Oxidative Stress; Prostatic Neoplasms; Xenograft Model Antitumor Assays | 2013 |
LACTIC DEHYDROGENASE ISOZYMES IN URINE.
Topics: Chromatography; Cystitis; Electrophoresis; Humans; Isoenzymes; Kidney Calculi; Kidney Diseases; Kidney Neoplasms; L-Lactate Dehydrogenase; Male; NADP; Nephrosis; Prostatic Hyperplasia; Prostatic Neoplasms; Pyelonephritis; Urinary Bladder Diseases; Urinary Bladder Neoplasms; Urine; Urology | 1964 |
Detection of a new N-oxidized metabolite of flutamide, N-[4-nitro-3-(trifluoromethyl)phenyl]hydroxylamine, in human liver microsomes and urine of prostate cancer patients.
Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Flutamide; Humans; Indicators and Reagents; Male; Microsomes, Liver; NADP; Prostatic Neoplasms; Spectrometry, Mass, Electrospray Ionization | 2006 |
Partial characterization of stromal and epithelial forms of 5 alpha-reductase in human prostate.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adolescent; Adult; Aged; Dihydrotestosterone; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; NADP; Oxidoreductases; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1981 |
Studies of the nuclear 5 alpha-reductase of human prostatic tissue: comparison of enzyme activities in hyperplastic, malignant, and normal tissues.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Acid Phosphatase; Dihydrotestosterone; Humans; Male; NADP; Oxidoreductases; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Tissue Distribution | 1983 |
Studies of the human testis. XIII. Properties of nicotinamide adenine dinucleotide (reduced form)-linked 17 alpha-hydroxylation.
Topics: Carbon Monoxide; Humans; Kinetics; Male; Microsomes; NAD; NADP; Oxidation-Reduction; Prostatic Neoplasms; Steroid 17-alpha-Hydroxylase; Steroid Hydroxylases; Testis | 1980 |
Prostatic cancer. I. 6-Methylene-4-pregnen-3-ones as irreversible inhibitors of rat prostatic delta 4-3 ketosteroid 5 alpha-reductase.
Topics: 5-alpha Reductase Inhibitors; Animals; Kinetics; Male; NADP; Oxidoreductases; Progesterone; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Testosterone | 1981 |
Studies on a 5 alpha-reductase inhibitor and their therapeutic implications.
Topics: 5-alpha Reductase Inhibitors; Animals; Antineoplastic Agents; Cell Nucleus; Chemical Phenomena; Chemistry, Physical; Humans; In Vitro Techniques; Kinetics; Male; NADP; Oxidoreductases; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Testosterone; Time Factors | 1981 |
Analysis of the oxidative catabolism of retinoic acid in rat Dunning R3327G prostate tumors.
Topics: Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Female; Imidazoles; Kinetics; Liver; Male; NADP; Oxidation-Reduction; Prostatic Neoplasms; Rats; Rats, Wistar; Tretinoin | 1996 |
Formation of 5alpha-androstane-3alpha,17beta-diol by normal and hypertrophic human prostate.
Topics: Adult; Age Factors; Aged; Androstane-3,17-diol; Androstanes; Cytosol; Dihydrotestosterone; Female; Humans; Male; Microsomes; Middle Aged; NAD; NADP; Organ Size; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Time Factors | 1977 |
C19O2-Steroid transformations in the human normal, hyperplastic and cancerous prostate.
Topics: Androstane-3,17-diol; Androstanols; Dihydrotestosterone; Humans; Hydroxysteroid Dehydrogenases; In Vitro Techniques; Male; Mixed Function Oxygenases; NADP; Oxidation-Reduction; Oxidoreductases; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1979 |
Inhibition of steroid 5 alpha-reductase by specific aliphatic unsaturated fatty acids.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Animals; Azasteroids; Dihydrotestosterone; Fatty Acids, Unsaturated; Female; Humans; Male; Microscopy, Electron; Microsomes, Liver; NADP; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Testosterone; Tumor Cells, Cultured | 1992 |
Comparison of the nuclear 5 alpha-reduction of testosterone and androstenedione in human prostatic carcinoma and benign prostatic hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstenedione; Cell Fractionation; Cell Nucleus; Humans; Kinetics; Male; NADP; Oxidation-Reduction; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1990 |
Interactions of retinoic acid and androgens in human prostatic tissue.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Carrier Proteins; Humans; Male; NADP; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Retinoic Acid; Tretinoin | 1990 |
An enzyme-amplified monoclonal immunoenzymometric assay for prostatic acid phosphatase.
Topics: Acid Phosphatase; Antibodies, Monoclonal; Cross Reactions; Epitopes; Humans; Immunoenzyme Techniques; Isoenzymes; Male; Methods; NAD; NADP; Prostate; Prostatic Neoplasms; Reference Values | 1985 |
Retinoic acid (RA): an inhibitor of 5 alpha-reductase in human prostatic cancer cells.
Topics: 5-alpha Reductase Inhibitors; Dose-Response Relationship, Drug; Humans; Male; NADP; Prostatic Neoplasms; Tretinoin; Tumor Cells, Cultured | 1987 |
Preliminary enzymatic studies of human benign prostate hypertrophy and prostatic cancer.
Topics: Adenocarcinoma; Diethylstilbestrol; Glucose-6-Phosphate Isomerase; Glucosephosphate Dehydrogenase; Humans; L-Lactate Dehydrogenase; Lymph Nodes; Male; NADP; Prostatic Hyperplasia; Prostatic Neoplasms; Pyruvate Kinase | 1972 |
Effects of a synthetic estrogen upon steroid bioconversion in vitro in testes of patients with prostatic cancer.
Topics: 17-alpha-Hydroxypregnenolone; Administration, Oral; Aged; Androstenedione; Enzyme Repression; Hexestrol; Humans; Hydroxyprogesterones; Hydroxysteroid Dehydrogenases; In Vitro Techniques; Isomerases; Lyases; Male; Middle Aged; Mixed Function Oxygenases; NADP; Progesterone; Prostatic Neoplasms; Spermatogenesis; Steroids; Testis; Testosterone | 1974 |
Hydroxysteroid dehydrogenases in normal and abnormal human testes.
Topics: Adolescent; Adult; Aged; Androgens; Child; Cryptorchidism; Dehydroepiandrosterone; Hernia, Inguinal; Histocytochemistry; Humans; Hydroxysteroid Dehydrogenases; Leydig Cells; Male; Middle Aged; NAD; NADP; Prostatic Neoplasms; Spermatic Cord Torsion; Testis | 1966 |